Novo Partners with Thermo Fisher for Wegovy Weight-Loss Drug Production
Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its weight-loss drug Wegovy. Thermo Fisher will be responsible for filling the Wegovy injection pens at its factory in North Carolina. Novo Nordisk is seeking to increase production of Wegovy to meet high demand in the United States, following production issues at its first contract manufacturer, Catalent. Wegovy, which launched in June 2021, is the first of its kind in a new class of highly effective weight-loss drugs.